Ouro Medicines

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$120M

Ouro Medicines is a biotechnology company developing immune reset therapeutics for chronic immune-mediated diseases, with a focus on B cell biology and T cell engagers.

Total Funding

$120M

Headquarters

San Francisco, USA

Founded

N/A

Website

ouromedicines.com

Focus Areas

Biotechnology

immune reset therapeutics

chronic immune-mediated diseases

BCMA-directed bispecific T cell engager

multiple myeloma

B cell biology

Investors